a questionnaire to provide information on current habits. For every DIE patient recruited (n = 143), two women without endometriosis (n = 288), two SUP patients (n = 288), and two OMA patients (n = 288) were recruited.
Results: For the overall population, factors significantly associated (P B 0.05) with DIE or OMA [Odds ratio (OR) [1] were: previous use of hormonal treatment for endometriosis [OR 6.66; 95% confidence interval (CI) 4.05-10.93];
previous surgery for endometriosis (OR 1.95; 95% CI 1.11-3.43); and living or working in a city or by a busy area (OR 1.66; 95% CI
INTRODUCTION
Endometriosis is an enigmatic disease characterized by the development of functional endometrial tissue outside the uterine cavity [1] . At a population level, an estimated 2-11% of women of reproductive age has endometriosis [2, 3] often experiencing substantial burden of disease, including chronic pelvic pain and infertility [4, 5] .
Symptoms of endometriosis can be non-discriminatory, so the initial indication of disease is normally based on a constellation of symptoms [6] . As such, endometriosis is characterized by long delays in diagnosis [7] , with up to 74% of patients receiving at least one false diagnosis [8] . Histologically, there are three phenotypes of endometriotic lesions: superficial peritoneal endometriosis (SUP), cystic ovarian endometriosis or endometrioma (OMA), and deep infiltrating endometriosis (DIE). The pathogenesis of endometriosis is unclear, and it is unknown why different patients present with SUP, OMA, or DIE lesions, and sometimes all the types present in the same patient. The fact that endometriosis phenotype pathogenesis remains elusive suggests that multifactorial mechanisms are involved [9] , including hormonal [10] , inflammatory [11, 12] , immunologic [13, 14] , genetic [15] [16] [17] , epigenetic [18] , environmental [19] , and other influences.
There is a need to recognize whether endometriosis presents in different ways in different populations. Population-based studies exploring the SUP, OMA, and DIE phenotypes have confirmed the genetic heterogeneity of endometriosis [15] , but offer little insight into the potential for regional variation.
The FEELING (Factors associated with the development of Endometrioma and dEep infiLtratING endometriosis) study (NCT01351051) aimed to identify clinical, lifestyle, and environmental factors associated with OMA and/or DIE. As the study took place over three diverse geographic regions, differences in endometriosis presentation were also compared descriptively.
METHODS

Study Design
This was three countries, incident case-control study conducted at seven hospital gynecologic departments in China (four centers), Russia (two centers), and France (one center) between May 2011 and April 2013. Females aged 18-41 years who had undergone surgery (laparoscopy or laparotomy) for a benign gynecologic indication in the last 3 months were considered for enrollment at their first routine post-surgical appointment with their usual physician (study visit).
Patients were eligible if they showed either no visible endometriosis lesions (control patient) or histologically confirmed endometriosis lesions. Histologically proven endometriotic lesions were classified into three groups: [20] SUP (control patient), OMA (case patient), or DIE (case patient). Endometriotic lesions were considered as DIE when the muscularis (bladder, intestine, and intrinsic ureter) was infiltrated by endometriotic tissue after radical surgery (e.g., bowel resection, partial cystectomy, and ureteral resection) [21] . 
Statistical Analysis
It was planned to enroll a total of 1008 patients (no endometriosis n = 288; SUP n = 288; OMA n = 288; DIE n = 144) to detect odds ratios (ORs)
C2 with a significance level of 5% and a power of 90%, and allowing for 20% missing/ non-evaluable questionnaires.
In the primary analysis, patients with SUP were regarded as controls and pooled with the no endometriosis group because of the uncertainties surrounding the real clinical significance of SUP [9] . Likewise, OMA and DIE were considered 'definite disease' and pooled [24] .
Univariate logistic regression analyses were performed at the first stage to screen all factors potentially associated with OMA or DIE. All variables with a P value below the 20% significance level in the univariate regressions were retained for the subsequent correlation analyses. Association between these retained variables was then tested using the appropriate method, depending on the nature of the variables. Association between a quantitative variable and a qualitative one was tested using Table 2 continued and 62.8%, respectively), but only one-third of patients with OMA.
Endometriosis History
In terms of endometriosis history ( Finally, more patients in Russia had a history of endometriosis in a first-degree relative.
Pre-Surgery Symptoms
Differences in pain reporting were observed between countries, with an overall trend towards the highest symptom reporting in the French group and the lowest symptom Table 5 continued (Table 6 ).
In the overall population, painful symptoms were more frequently reported in patients with endometriosis when compared to those without endometriosis. The frequency of painful symptoms seemed to be correlated with the endometriosis phenotype and increased with the severity of the lesions: SUP, OMA, and DIE ( Fig. 1a) . Similar trends were observed for the intensity of pain/discomfort symptoms according to the visual analog scale, with Chinese patients reporting the lowest intensities ( Fig. 1b) . While the incidence of symptoms appeared to be correlated with Fig. 1 regions. This is the first study, to our knowledge, to examine the relationship between such factors and endometriosis, and supports the theory that DIE and OMA have complex, multifaceted origins. The data highlight interesting regional differences, Pain reporting varied between countries, possibly related to cultural influences, rather than actual differences in pain experienced.
Indeed, most (82%) French patients reported that dysmenorrhea impacted their lives vs only 44% of Chinese patients. Furthermore, deep dyspareunia was more frequent in French women without endometriosis (50%) than in Chinese women with endometriosis (15.4%). These findings suggest potentially different health care experiences and/ or expectations between patients from different regions. In addition, multiple studies suggest that cultural norms may influence individual conceptualization of pain and affect health-seeking behavior [26] [27] [28] . Although French patients reported more pain, they also tolerated longer duration between pain and treatment, which may reveal differences in treatment acceptability and/or health care system efficiencies. were associated with OMA and/or DIE and not etiologic factors. Ideally, these data would have been collected prior to revealing the surgery results. In addition, a large quantity of data was collected retrospectively at the study visit, which makes causality and temporality difficult to assess, and is subject to recall bias.
Studies
The main objective of this study was not inter-country comparison. Thus, no formal monitoring of translations or assessment of literal translation accuracy across sites was carried out; however, translations were carried out at a country level, so translation accuracy and cultural competencies can be assumed. Low patient numbers in national groups by endometriosis type limit both inter-and intra-country comparisons; although numeric within-country differences were noted across endometriosis types, few were significant. Nevertheless, the importance of our findings should not be underestimated.
CONCLUSION
In conclusion, we show substantial differences in the symptoms and management of endometriosis phenotypes across three diverse countries, which suggest that this multifactorial, complex condition cannot be generalized on a global scale. Larger studies, taking into account geographic, cultural, and health care differences between patients, are required to confirm the initial findings reported here, with the goal of assisting investigators in achieving earlier patient risk stratification and diagnosis within routine clinical practice. 
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